MedTrace Logo

External Nasal Dilator and Oxygen Therapy in Respiratory Failure

NCT02662387 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2017-08-21

Study results available
· View outcomes & findings →

Summary

Acute respiratory failure secondary to bronchiolitis and asthma is one of the most common diagnoses in children admitted to pediatric intensive care unit.

Objectives: The primary outcome of the study is to compare the respiratory parameters between patients on HFNC and HFNC with ENDs.

Methods: This is a prospective randomized controlled trial. All children admitted to Loma Linda University Children's Hospital due to acute respiratory failure secondary to bronchiolitis and asthma are eligible for inclusion in the study. Multiple respiratory parameters will be collected as part of the study. The investigators anticipate that use of END will have a positive impact on the respiratory status of children with acute respiratory failure. Appropriate statistical analysis of the data will occur after the data has been de-identified.

Conditions

  • Acute Respiratory Failure

Interventions

DEVICE

External nasal dilator (END)

Applying External nasal dilator as adjuvant to high flow oxygen

OTHER

High flow nasal cannula (HFNC)

Non-invasive positive pressure ventilation

Sponsors & Collaborators

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Janeth Ejike, MD · Loma Linda University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-02
Primary Completion
2016-05-19
Completion
2016-06-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02662387 on ClinicalTrials.gov